Can I read Apremilast Efficacy in Pediatric Psoriasis on EtoBox?

Apremilast Efficacy in Pediatric Psoriasis by jupiterclinicbooking is a document available to read on EtoBox.

What is Apremilast Efficacy in Pediatric Psoriasis about?

The SPROUT study evaluated the efficacy and safety of apremilast in pediatric patients aged 6-17 with moderate-to-severe plaque psoriasis over 16 weeks. Results showed that significantly more patients treated with apremilast achieved a response in global disease activity compared to placebo, with no new safety concerns identified. These findings support apremilast as a viable oral systemic therapy for pediatric psoriasis, addressing the limited treatment options available for this population.

Author

jupiterclinicbooking

Language

EN